In a dedicated phase 2a trial studying participants with MASLD (formerly NAFLD), retatrutide achieved resolution of liver steatosis in over 85% of participants
Furthermore, lifestyle choices and habits are integral to sustainable weight loss
Impaired kidney function significantly extends GHK-Cu clearance time
Cui Y, Liao M, Xu A, Chen G, Liu J, Yu X, et al
This delivery method bypasses the digestive system, allowing for optimal absorption and immediate availability for the liver to aid in detoxification
Tirzepatide (the active ingredient in Zepbound and Mounjaro is an injectable that targets two hormone receptors: GLP-1 and GIP